161 related articles for article (PubMed ID: 12847754)
1. Drug samples: friend or foe?
Coolidge MP
J Drugs Dermatol; 2002 Jul; 1(1):49-52. PubMed ID: 12847754
[TBL] [Abstract][Full Text] [Related]
2. Drug samples: friend or foe?
Burkhart CG
J Drugs Dermatol; 2002 Sep; 1(2):123-4. PubMed ID: 12847733
[No Abstract] [Full Text] [Related]
3. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
Brand R
State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
[No Abstract] [Full Text] [Related]
4. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages.
Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586
[No Abstract] [Full Text] [Related]
5. Drug samples are meant for advertising.
Thawani V
Issues Med Ethics; 2001; 9(3):91. PubMed ID: 16334483
[No Abstract] [Full Text] [Related]
6. The price of seduction: direct-to-consumer advertising of prescription drugs in the US.
Marks JH
N C Med J; 2003; 64(6):292-5. PubMed ID: 14983622
[No Abstract] [Full Text] [Related]
7. Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines.
Kyle GJ; Nissen LM; Tett SE
J Clin Pharm Ther; 2008 Oct; 33(5):553-9. PubMed ID: 18834371
[TBL] [Abstract][Full Text] [Related]
8. [Drug marketing: methods, effect and regulation].
Søndergaard J; Koefoed MM; Andersen M
Ugeskr Laeger; 2009 Mar; 171(10):778-80. PubMed ID: 19265598
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical industry marketing: understanding its impact on women's health.
Sufrin CB; Ross JS
Obstet Gynecol Surv; 2008 Sep; 63(9):585-96. PubMed ID: 18713478
[TBL] [Abstract][Full Text] [Related]
10. The pharmaceutical industry--to whom is it accountable?
Holmer AF
N Engl J Med; 2000 Nov; 343(19):1415; discussion 1417. PubMed ID: 11183877
[No Abstract] [Full Text] [Related]
11. Selling prescription drugs to the consumer: with Vioxx's withdrawal, new questions on a $3.8 billion ad business.
Elliott S; Ives N
N Y Times Web; 2004 Oct; ():C1, C9. PubMed ID: 15487065
[No Abstract] [Full Text] [Related]
12. Stretching the managed care dollar in the new millennium: the practice of detailing primary care physicians.
Hill CD; Bunn DN; Hawkins JR
Manag Care Q; 2002; 10(2):18-23. PubMed ID: 12148477
[TBL] [Abstract][Full Text] [Related]
13. Drug advertisements: what a physician should know.
Ghosh RK; Ghosh SM
N Z Med J; 2010 May; 123(1314):154-6. PubMed ID: 20581923
[No Abstract] [Full Text] [Related]
14. Direct-to-consumer offers for free and discounted medications on the internet: a content analysis of "e-samples".
Weppner WG; Hollon MF; Chew LD; Larson EB
Arch Intern Med; 2009 Nov; 169(21):2024-30. PubMed ID: 19933966
[No Abstract] [Full Text] [Related]
15. Medicine and the pharmaceutical industry: what's right, what's wrong, and what's to come.
Tan SY
Singapore Med J; 1998 Mar; 39(3):91-5. PubMed ID: 9632964
[No Abstract] [Full Text] [Related]
16. Direct-to-consumer advertising: impact on prescribing.
Child Health Alert; 2005 Jun; 24():5-6. PubMed ID: 16134243
[No Abstract] [Full Text] [Related]
17. Increased direct-to-consumer advertising driving pharmaceutical costs, trends.
Fine A
Exec Solut Healthc Manag; 1999 Jan; 2(1):2-3. PubMed ID: 10345986
[No Abstract] [Full Text] [Related]
18. [Physicians and drug industry: attitudes and practice].
Aasland OG; Førde R
Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2603-6. PubMed ID: 15534631
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceuticals and medical devices: business practices.
Jones TM
Issue Brief Health Policy Track Serv; 2009 Jan; ():1-54. PubMed ID: 19297719
[No Abstract] [Full Text] [Related]
20. Is the science of medicine trumping the art of medicine?
Bujak JS; Lister E
Physician Exec; 2006; 32(5):18-21. PubMed ID: 17007307
[No Abstract] [Full Text] [Related]
[Next] [New Search]
